|
|
|
|
|
|
Don’t Let Adhesions Block the Way
Adhesions are a common result of surgery — with potentially serious consequences:
- Risk of complications for patients, including infertility1, chronic pelvic pain2, and reoperation for adhesive small bowel obstruction.3
- Complications during future surgeries, including risk of inadvertent damage to organs and tissues, due to the need for extensive adhesiolysis.4
- Compromised conditions for effective intraperitoneal chemotherapy5, pelvic radiotherapy6, and future laparoscopy.5
SEPRAFILM Adhesion Barrier is proven safe and effective in reducing adhesions in abdominopelvic laparotomy. No adhesion barrier has been more extensively evaluated in abdominopelvic surgery.7 In a clinical trial, patients treated with SEPRAFILM showed a 48% relative reduction in adhesions and were 8.5 times more likely to be adhesion-free as compared to untreated controls.8 Studies also show that SEPRAFILM reduced adhesion-related morbidities at reoperation.9,10
With more than 1 million patients treated and more than 10 years of clinical use, you can feel confident about SEPRAFILM. Learn how SEPRAFILM Adhesion Barrier can help prevent adhesions in your surgical practice.
|
|
|